Tuesday - June 2, 2026
Royal Marsden NHS Foundation Trust: Combination Immunotherapy Significantly Reduces Kidney Cancer Recurrence After Surgery
June 02, 2026
LONDON, England, June 2 (TNSxrep) -- The Royal Marsden National Health Service Foundation Trust issued the following news:

* * *

Combination immunotherapy significantly reduces kidney cancer recurrence after surgery

The latest findings from the RAMPART trial were presented by Professor James Larkin at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.

*

Results from the international Phase III RAMPART trial were . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products